Study of REGN3500 and Dupilumab in Patients With Asthma
Clinical trial NCT03112577 · COMPLETED
Trial details
- NCT number
- NCT03112577
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2019-03-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.